April 24, 2017

Dan Alford, MD, MPH; Phillip Coffin, MD; Melissa Weimer, DO, MCR

Begin Course  View Presentation Slides

Educational objectives:

  • Describe universal precautions and their role in opioid therapy
  • Review monitoring and documentation strategies for opioid therapy
  • Explain the fundamental principles of urine drug testing and interpretation
  • List the differential diagnosis for aberrant drug related behavior
  • Describe when naloxone co-prescription should be considered

American Academy of Addiction Psychiatry (AAAP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

American Academy of Addiction Psychiatry (AAAP)  designates this enduring material for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Accreditation:
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1 Category 1 credits for completing this activity.

Method of participation in the learning process:
In order to receive a maximum of 1 AMA PRA Category 1 Credit™, participants must participate in the entire module, answer post-test questions, pass with a 70% pass rate and complete an evaluation at the end of the activity.